Skip to search formSkip to main contentSkip to account menu

L 654066

Known as: L-654,066 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
A rapid and specific assay, based on liquid chromatography-atmospheric pressure chemical ionization mass spectrometry, for the determination of MK-434 (a 5 alpha-reductase inhibitor) and its…
1994
1994
Pharmacodynamics of MK‐0963, a new 5α‐reductase inhibitor: Effects on serum androgen concentrations
The hormonal effects after a 10‐day administration of a 4‐azasteroid inhibitor of 5α‐reductase, MK‐0963 (previously L‐654,066… 
1992
1992
Determination of L-654,066, a new 5 alpha-reductase inhibitor in plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.
L-654,066 is a new 5 alpha-reductase inhibitor. A sensitive and specific assay based on combined liquid chromatography/mass… 
1992
1992
Pharmacodynamics and tolerability of L‐654,066, a steroid 5α‐reductase inhibitor, in men
A four‐period, two‐panel single rising‐dose study (0.1 to 100 mg) was conducted in healthy men to investigate the… 
1992
1992
Pharmacodynamics and tolerability of L-654,066, a steroid 5 alpha-reductase inhibitor, in men.
A four-period, two-panel single rising-dose study (0.1 to 100 mg) was conducted in healthy men to investigate the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)